Recommended videos
Threshold Pharmaceuticals THLD
20 views
CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold?s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012.
Date:
2012. 02. 04.
Add to list
Recommended videos

Facebook
X / Twitter
Tumblr
Reddit
Telegram
WhatsApp
LinkedIn
E-mail